ClassID:

170822

G01N2800/162 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Ophthalmology Conjunctival disorders, e.g. conjunctivitis

Recent Application in this class:
#1
20240377391
2024-11-14

Point of Care Device for Detection of Analytes in Tear Film and Other Biological Samples

#2
20240230669
2024-07-11

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#3
20230079291
2023-03-16

METHOD FOR MEASURING TEAR CONSTITUENTS IN A TEAR SAMPLE

#4
20210231684
2021-07-29

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#5
20210011004
2021-01-14

METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL

#6
20200278299
2020-09-03

Method for visualization of conjunctival cells using fluoroquinolone antibiotics and method for diagnosis of ocular lesions using the same

#7
20200174017
2020-06-04

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#8
20200141945
2020-05-07

Method for measuring tear constituents in a tear sample

#9
20190302028
2019-10-03

Method for Measuring Tear Constituents in a Tear Sample

#10
20190212342
2019-07-11

Method for measuring tear constituents in a tear sample

#11
20180246081
2018-08-30

METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL

#12
20170322227
2017-11-09

Compositions and methods for treating eye infections and disease

#13
20170322226
2017-11-09

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#14
20170176457
2017-06-22

Compositions and methods for treating eye infections and disease

#15
20160282252
2016-09-29

BIOMARKER NORMALIZATION

#16
20150125394
2015-05-07

METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL

#17
20150011475
2015-01-08

Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method

#18
20120245090
2012-09-27

Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and pharmaceutical composition obtained by the method

#19
20120060590
2012-03-15

Biomarker normalization

#20
20110318274
2011-12-29

Variant of mite allergen and uses thereof

#21
20110144919
2011-06-16

Biomarker normalization

#22
20090298101
2009-12-03

Blood C5a Levels as an Indicator of Rhinoconjunctivitis Severity

#23
20090068162
2009-03-12

Stationary Phase Antibody Arrays for Trace Protein Analysis

#24
20080264152
2008-10-30

Biomarker normalization

#25
20070212353
2007-09-13

Therapeutic target and diagnostic marker for asthma and related conditions